Cowan Chad (CIK 2039294) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-03). Recent activity: Sell IPSC (1,365 shares), Sell IPSC (1,431 shares), Buy IPSC (135,000 shares), Sell IPSC (1,611 shares), Buy IPSC (58,060 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-03 | Century Therapeutics, Inc. (IPSC) | Chief Scientific Officer | Sell | 1,365 | $2,989 |
| 2026-03-13 | Century Therapeutics, Inc. (IPSC) | Chief Scientific Officer | Sell | 1,431 | $3,907 |
| 2026-02-04 | Century Therapeutics, Inc. (IPSC) | Chief Scientific Officer | Buy | 135,000 | $0 |
| 2026-01-06 | Century Therapeutics, Inc. (IPSC) | Chief Scientific Officer | Sell | 1,611 | $1,611 |
| 2025-12-29 | Century Therapeutics, Inc. (IPSC) | Chief Scientific Officer | Buy | 58,060 | $49,351 |
| 2025-11-24 | Century Therapeutics, Inc. (IPSC) | Chief Scientific Officer | Sell | 5,462 | $2,731 |
| 2025-09-22 | Century Therapeutics, Inc. (IPSC) | Chief Scientific Officer | Buy | 762,543 | $0 |
| 2025-03-12 | Century Therapeutics, Inc. (IPSC) | Chief Scientific Officer | Buy | 19,500 | $0 |
Source: SEC Form 4 filings · as of 2026-04-03